BCII Enterprises Inc.
BCII
$0.019
$0.0015.56%
| Weiss Ratings | BCII - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | BCII - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | BCII - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.23 | |||
| Price History | BCII - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.83% | |||
| 30-Day Total Return | 24.18% | |||
| 60-Day Total Return | -19.15% | |||
| 90-Day Total Return | 17.28% | |||
| Year to Date Total Return | 5.56% | |||
| 1-Year Total Return | -23.39% | |||
| 2-Year Total Return | -72.86% | |||
| 3-Year Total Return | -89.30% | |||
| 5-Year Total Return | -97.29% | |||
| 52-Week High % Change | -48.51% | |||
| 52-Week Low % Change | 85.37% | |||
| Price | BCII - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.04 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Oct 28, 2024 | |||
| 52-Week High Price (Date) | Dec 18, 2024 | |||
| Valuation | BCII - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 986.04K | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BCII - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BCII - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 925 292 6226 | |||
| Address | 53 Calle Las Palmeras San Juan, PR 00901 | |||
| Website | www.bciienterprises.com | |||
| Country | United States | |||
| Year Founded | 1995 | |||
| Profitability | BCII - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -378.50% | |||
| Profit Margin | -282.67% | |||
| Management Effectiveness | BCII - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | BCII - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.58M | |||
| Total Revenue (TTM) | 1.58M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 1.25M | |||
| EBITDA (TTM) | -5.96M | |||
| EBIT (TTM) | -5.99M | |||
| Net Income (TTM) | -4.47M | |||
| Net Income Avl. to Common (TTM) | -4.47M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -7,118.43% | |||
| EPS Diluted (TTM) | -0.13 | |||
| EPS Diluted Growth (Q YOY) | -3,195.52% | |||
| Balance Sheet | BCII - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.12M | |||
| Cash Per Share (Q) | $0.03 | |||
| Total Current Assets (Q) | 1.27M | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -446.70K | |||
| Current Ratio (Q) | 0.711 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 1.78M | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | -447.00K | |||
| Cash Flow | BCII - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -7.48M | |||
| Cash from Financing (TTM) | 3.52M | |||
| Net Change in Cash (TTM) | 519.00K | |||
| Levered Free Cash Flow (TTM) | -755.60K | |||
| Cash from Operations (TTM) | 4.48M | |||
